Literature DB >> 7663613

Tuberculosis in children.

J R Starke1.   

Abstract

The World Health Organization estimates that 90 million cases of tuberculosis will occur throughout the world in the 1990s, and 30 million people will die from the disease. Although traditional epidemiology suggested that 90% of tuberculosis cases arise from reactivation of remote infection, urban studies in the United States using DNA fingerprinting techniques imply that up to 40% of current cases are due to recent acquisition, a finding that will alter some basic approaches to tuberculosis control. Drug resistance is emerging as a major obstacle to tuberculosis control in the United States and the world. New studies focusing on the genetic basis of drug resistance may lead to better diagnostic techniques and new drugs. New trends in treatment center on shorter but more intense and directly observed therapy to maintain adherence. The new emphasis in developed countries is to concentrate control efforts selectively on those individuals, with the greatest risk factors for development of tuberculosis infection and disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7663613     DOI: 10.1097/00008480-199506000-00005

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  3 in total

1.  The stringent response of Mycobacterium tuberculosis is required for long-term survival.

Authors:  T P Primm; S J Andersen; V Mizrahi; D Avarbock; H Rubin; C E Barry
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

2.  Characterization of the cydAB-encoded cytochrome bd oxidase from Mycobacterium smegmatis.

Authors:  B D Kana; E A Weinstein; D Avarbock; S S Dawes; H Rubin; V Mizrahi
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

3.  MULTIDRUG - RESISTANT TUBERCULOSIS (MDRTB) IN CHILDREN.

Authors:  P L Prasad; C G Wilson; M M Harjai; K Chand
Journal:  Med J Armed Forces India       Date:  2011-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.